Search

everythinglearnresearchcommunity

for

Search:↓

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Pegvaliase is recommended for treating adults with phenylketonuria.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

PRP may improve fertility treatment success but needs more research for safe use.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Follicular Unit Transplantation is a precise hair restoration technique that requires careful planning and a skilled team, and Follicular Unit Extraction offers a less invasive option.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.